Stay updated with breaking news from Use Thereof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mayne Pharma LLC is suing generic drug manufacturer Perrigo over alleged infringement of the plaintiff’s patent covering drug product Lexette. According
/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into a research and option license...
Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement - read this article along with other careers information, tips and advice on BioSpace
Health your username May 3, 2021 Mayne Pharma LLC is suing generic drug manufacturer Perrigo over alleged infringement of the plaintiff’s patent covering drug product Lexette. According to Thursday’s complaint filed in the District of Delaware, the plaintiff is the sole assignee of United States Patent No. 10,857,159, entitled “Halobetasol Foam Composition and Method of Use Thereof,” which covers Lexette, a topical used to treat skin conditions such as psoriasis. The U.S. Patent and Trademark Office issued the patent Dec. 8, 2020, to Robert T. Gauthier and James D. Hammer, the complai...